FIGURE
Fig. S7
- ID
- ZDB-FIG-170914-51
- Publication
- Zoni et al., 2017 - CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. S7
GRP78 KD reduces invasion and tumor growth in vivo. A) PC-3MPro4Luc2_dTomato human prostate cancer cells with GRP78 knockdown were injected into the duct of Cuvier to monitor extravasation and formation of distant metastases in vivo with 30 embryos injected per group. B-C) GRP78 knockdown reduces extravasation and tumor growth significantly at 4dpi (days post injection) at the caudal hematopoietic tissue (CHT). No effect on tumor burden is observed. Error Bars ± SEM. (Blind observations). **, P<0,01. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Oncogene